GOT GAS: Is white hydrogen the magic bullet?
Naturally occurring hydrogen is also known as ‘white’ or ‘gold’ hydrogen White could offer significant cost and emissions advantages relative to some other means of [more…]
Rise and Shine: Everything you need to know before the ASX opens
On Stockhead today, Pilbara Minerals’ trendsetting lithium auction is back, baby! Can it heat up mild spodumene prices? But first, the day ahead. WHO’S [more…]
Pilbara Minerals’ trendsetting lithium auction is back, baby! Can it heat up mild spodumene prices?
In search of price discovery, Pilbara Minerals restarts BMX auctions while Albemarle puts its own spodumene under the hammer PLS pulls in US$1200/dmt on a [more…]
Tesla’s Troubled Trajectory: From Tech Titan to S&P’s Lowest Performer
Once hailed as the beacon of innovation in the automotive industry, Tesla faces an existential crisis under Elon Musk’s leadership. Positioned as a critical player [more…]
Trump Seeks Dismissal of Classified Records Case, Claiming Legal Right to Retain Documents
In a bold legal move, Donald Trump’s defense team is poised to request a federal judge in Fort Pierce, Florida, to dismiss the charges against [more…]
Top tier, cool climate cab sav from the Hills? Howard’s way is back in vogue
A new generation of winemakers is putting its fingerprints on the vibrant Adelaide Hills scene, elevating the quality of cool-climate wines being produced amid the [more…]
Closing Bell: ASX a little lower after hosting a Big 4 bank midweek spank
Local markets end lower on big bank sell-off Material gains offset by Telco’s and Financials Small Caps led by rare earths developer Arafura Local [more…]
Monsters of Rock: Analysts split on Liontown loan, copper miners ride price surge higher
Gold Road to miss in March quarter as rain hits Gruyere mine hard Analysts give their take on Liontown debt package Copper miners surge as [more…]
PharmAust files groundbreaking MND/ALS clinical data with the FDA
Phase 1 MEND study outcomes for MND/ALS treatment now with FDA for review in support of PharmAust’s Orphan Drug Designation request Clinical data shows monepantel [more…]
Long Shortz with GCX Metals: Dancing into drilling at Dante
Stockhead’s Ashtyn Hiron sits down with GCX Metals (ASX:GCX) CEO and managing director Thomas Line to get the short end of the long story on [more…]